Drima Pharmaceuticals Private Limited
About Drima Pharmaceuticals Private Limited
Data last updated:
Drima Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 05 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC288137. Its GSTIN is 09AAFCD9365D1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mahendra Kumar Bhagwani and Ramoo Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.1 Lakh, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹4,578 (net margin 0.9%) and EBITDA of ₹6,188 (EBITDA margin 1.2%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Drima Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressIndira Nagar J.B. Marg Mankhurd Panvel Link Road Govandi Chem, Bur, Mumbai, Maharashtra, India – 400043
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Drima Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Drima Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Drima Pharmaceuticals Private Limited, buy the company report.
Financials of Drima Pharmaceuticals Private Limited
FY 2024 filings availableDrima Pharmaceuticals Private Limited reported revenue of ₹5.1 Lakh (down 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 25% fall in the latest year. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6,188 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,578 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Drima Pharmaceuticals Private Limited, buy the company report.
Board of directors of Drima Pharmaceuticals Private Limited
Drima Pharmaceuticals has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahendra Kumar Bhagwani | Director | 05 Dec 2016 | 9 Years 10 Months | Current |
| Ramoo Kumar | Director | 05 Dec 2016 | 9 Years 10 Months | Current |
| Harishankar Prajapati | Director | 05 Dec 2016 | 9 Years 10 Months | Current |
| Dheeraj Panday | Director | 05 Dec 2016 | 9 Years 10 Months | Current |
| Anil Kumar Gupta | Director | 05 Dec 2016 | 9 Years 10 Months | Current |
Peer comparison
Drima Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Terveks Pharmaceuticals Private Limited | ₹5.14 Lakh (FY 2025) | -52.0% | Jamshedpur, Jharkhand, India | |||
| Stenmax Pharmaceuticals Private Limited | ₹5.13 Lakh (FY 2025) | -16.0% | New Delhi, Delhi, India | |||
| Drima Pharmaceuticals Private Limitedthis company | ₹5.1 Lakh (FY 2024) | ₹4,578 | 0.9% | -25.0% | Mumbai, Maharashtra, India | |
| Asaan Pharmaceuticals Private Limited | ₹5.08 Lakh (FY 2015) | 88.0% | Bhopal, Madhya Pradesh, India | |||
| Calvert Pharmaceuticals Private Limited | ₹5.07 Lakh (FY 2024) | Mumbai, Maharashtra, India | ||||
| Mediction Pharmaceuticals Private Limited | ₹5.06 Lakh (FY 2020) | 39.0% | New Delhi, Delhi, India |
To see the full peer comparison of Drima Pharmaceuticals Private Limited, buy the company report.
Auditor
Drima Pharmaceuticals Private Limited is audited by KDV AND COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KDV AND COMPANY | FY 2017 | 135180W |
Shareholding
The shareholding of Drima Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Drima Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Drima Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Drima Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Drima Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCD9365D1ZG | Uttar Pradesh | Active | 26 May 2018 |
To see the full GST registrations and return filing status of Drima Pharmaceuticals Private Limited, buy the company report.
Recent activity
Drima Pharmaceuticals Private Limited has 6 board changes on record since 2016: 5 appointments and 1 cessation. The latest: Ishwar Sharan Srivastava ceased to be Director on 09 Dec 2020.
Frequently asked questions
Drima Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 05 December 2016 (10+ years old) and is registered under CIN U74999MH2016PTC288137.
Drima Pharmaceuticals has 5 current directors:
- Mahendra Kumar Bhagwani - Director
- Ramoo Kumar - Director
- Harishankar Prajapati - Director
- Dheeraj Panday - Director
- Anil Kumar Gupta - Director
The latest financial statements of Drima Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Drima Pharmaceuticals is 09AAFCD9365D1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Drima Pharmaceuticals is U74999MH2016PTC288137. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Drima Pharmaceuticals was incorporated on 05 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Drima Pharmaceuticals by revenue are Terveks Pharmaceuticals Private Limited, Stenmax Pharmaceuticals Private Limited, Asaan Pharmaceuticals Private Limited, Calvert Pharmaceuticals Private Limited, Mediction Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ishwar Sharan Srivastava ceased to be Director on 09 Dec 2020. Anil Kumar Gupta was appointed as Director on 05 Dec 2016. Dheeraj Panday was appointed as Director on 05 Dec 2016. Drima Pharmaceuticals has 6 board changes on record in total.
The registered office of Drima Pharmaceuticals is at Indira Nagar J.B. Marg Mankhurd Panvel Link Road Govandi Chem, Bur, Mumbai, Maharashtra, India – 400043.
Drima Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Drima Pharmaceuticals is compliant as of 15 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
